Literature DB >> 168626

Studies on immunisation of pigs with the Bartha strain of Aujeszky's disease virus.

J B McFerran, C Dow.   

Abstract

The K strain of Aujeszky's disease virus (ADV) grown in Vero cells was used to vaccinate pigs. Following intramuscular inoculation, the pigs remained healthy, no vaccine virus was excreted and virus could be detected only at the inoculation site. One inoculation gave good protection against challenge with a virulent strain of ADV, and the amount of virulent ADV excreted was geatly curtailed. Following vaccination only low leads of serum neutralizing antibody were detected (geometric mean titre 1/2), but three weeks after challenge very high levels were found (GMT 1/1773). Intranasal vaccination gave similar results. There was minimal excretion of vaccine virus. The clinical reaction on challenge was less severe than in the intramuscularly challenged group, although lower antibody levels were detected three wekks following challenge (GMT 1/483). A field trial, using this strain given subcutaneously, indicated that one inoculation of this vaccine is effective.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 168626

Source DB:  PubMed          Journal:  Res Vet Sci        ISSN: 0034-5288            Impact factor:   2.534


  24 in total

1.  The unusual fold of herpes simplex virus 1 UL21, a multifunctional tegument protein.

Authors:  Claire M Metrick; Pooja Chadha; Ekaterina E Heldwein
Journal:  J Virol       Date:  2014-12-24       Impact factor: 5.103

2.  A review of pseudorabies (Aujeszky's disease) in pigs.

Authors:  J Y Lee; M R Wilson
Journal:  Can Vet J       Date:  1979-03       Impact factor: 1.008

3.  Multiplication and distribution of Aujeszky's disease (pseudorabies) virus in vaccinated and non-vaccinated pigs after intranasal infection.

Authors:  G Wittmann; J Jakubik; R Ahl
Journal:  Arch Virol       Date:  1980       Impact factor: 2.574

4.  Suppression of the interferon-mediated innate immune response by pseudorabies virus.

Authors:  Alla Brukman; L W Enquist
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

Review 5.  Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine.

Authors:  Lisa E Pomeranz; Ashley E Reynolds; Christoph J Hengartner
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

6.  Protective antiviral immune responses to pseudorabies virus induced by DNA vaccination using dimethyldioctadecylammonium bromide as an adjuvant.

Authors:  Eugene M A van Rooij; Harrie L Glansbeek; Luuk A T Hilgers; Eddie G te Lintelo; Yolanda E de Visser; Wim J A Boersma; Bart L Haagmans; Andre T J Bianchi
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

7.  Glycoprotein D-negative pseudorabies virus can spread transneuronally via direct neuron-to-neuron transmission in its natural host, the pig, but not after additional inactivation of gE or gI.

Authors:  W Mulder; J Pol; T Kimman; G Kok; J Priem; B Peeters
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

8.  Characterization of the pseudorabies virus-specific immunoglobulin M response and evaluation of its diagnostic use in pigs with preexisting immunity to the virus.

Authors:  T G Kimman
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Deleting valine-125 and cysteine-126 in glycoprotein gI of pseudorabies virus strain NIA-3 decreases plaque size and reduces virulence in mice.

Authors:  L Jacobs; H J Rziha; T G Kimman; A L Gielkens; J T Van Oirschot
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

10.  Cellular immune response to hog cholera virus (HCV): T cells of immune pigs proliferate in vitro upon stimulation with live HCV, but the E1 envelope glycoprotein is not a major T-cell antigen.

Authors:  T G Kimman; A T Bianchi; G Wensvoort; T G de Bruin; C Meliefste
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.